131506-24-6

Basic information

• Product Name: Glycine, N-(2,3-dihydro-1H-inden-2-yl)-N-[N-[(phenylmethoxy)carbonyl]-L-valyl]-
• CAS NO: 131506-24-6
• Molecular Formula: C24H28N2O5
• Molecular Weight: 424.497
• Mol File: 131506-24-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Glycine, N-(2,3-dihydro-1H-inden-2-yl)-N-[N-[(phenylmethoxy)carbonyl]-L-valyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Glycine, N-(2,3-dihydro-1H-inden-2-yl)-N-[N-[(phenylmethoxy)carbonyl]-L-valyl]-(131506-24-6)
• EPA Substance Registry System: Glycine, N-(2,3-dihydro-1H-inden-2-yl)-N-[N-[(phenylmethoxy)carbonyl]-L-valyl]-(131506-24-6)

Safety Data

• Hazardous Substances Data: 131506-24-6(Hazardous Substances Data)

Upstream product

• 80871-69-8 N-(2,3-dihydro-1H-inden-2-yl)glycine ethyl ester hydrochloride 
• 1149-26-4 (S)-N-(benzyloxycarbonyl)valine 
• 131506-23-5 N-(carbobenzyloxy)-L-valyl-N-(2,3-dihydro-1H-inden-2-yl)glycine ethyl ester 

Downstream Products

• 137301-78-1 4-(4-Chloro-benzenesulfonylaminocarbonyl)-N-{(S)-1-[({(S)-1-[hydroxy-(4-trifluoromethyl-phenyl)-methyl]-2-methyl-propylcarbamoyl}-methyl)-indan-2-yl-carbamoyl]-2-methyl-propyl}-benzamide 
• 137301-79-2 (2S)-<<4-<<<(4-chlorophenyl)sulfonyl>amino>carbonyl>phenyl>oxomethyl>-L-valyl-N-(2,3-dihydro-1H-inden-2-yl)glycine N-<2-<3-methyl-1-<4-(trifluoromethyl)phenyl>-1-oxobutyl>>amide 
• 137301-88-3 (3S,2RS)-N-<<4-<<<(4-chlorophenyl)sulfonyl>amino>carbonyl>phenyl>oxomethyl>-L-valyl-N-(2,3-dihydro-1H-inden-2-yl)glycine N-<3-(1,1,1-trifluoro-4-phenyl-2-hydroxybutyl)>amide 
• 137301-89-4 (3S)-<<4-<<<(4-chlorophenyl)sulfonyl>amino>carbonyl>phenyl>oxomethyl>-L-valyl-N-(2,3-dihydro-1H-inden-2-yl)glycine N-<3-(1,1,1-trifluoro-4-phenyl-2-oxobutyl)>amide 
• 137302-12-6 4-(4-Bromo-benzenesulfonylaminocarbonyl)-N-((S)-1-{indan-2-yl-[(3,3,3-trifluoro-1-isopropyl-2-oxo-propylcarbamoyl)-methyl]-carbamoyl}-2-methyl-propyl)-benzamide 
• 131565-79-2 (3RS)-N-{[4-({[(4-chlorophenyl)sulfonyl]amino}carbonyl)phenyl]oxomethyl}-L-valyl-N-(2,3-dihydro-1H-inden-2-yl)glycine N-[3-(1,1,1-trifluoro-4-methyl-2-oxopentyl)]amide 
• 129585-42-8 (2RS)-N-<<4-<<<(4-chlorophenyl)sulfonyl>amino>carbonyl>phenyl>oxomethyl>-L-valyl-N-(2,3-dihydro-1H-inden-2-yl)glycine N-<3-(1,1,1-trifluoro-3-methyl-2-oxobutyl)>amide 
• 131541-25-8 <(2R,3S)+(2S,3R)>-N-<<4-<<<(4-chlorophenyl)sulfonyl>amino>carbonyl>phenyl>oxomethyl>-L-valyl-N-(2,3-dihydro-1H-inden-2-yl)glycine N-<3-(1,1,1-trifluoro-4-methyl-2-hydroxypentyl)>amide 
• 137301-98-5 (2RS)-N-<<4-<<<(4-chlorophenyl)sulfonyl>amino>carbonyl>phenyl>oxomethyl>-L-valyl-N-(2,3-dihydro-1H-inden-2-yl)glycine N-<3-(1,1,1-trifluoro-3-methyl-2-hydroxybutyl)>amide 
• 137332-51-5 4-(4-Chloro-benzenesulfonylaminocarbonyl)-N-((S)-1-{indan-2-yl-[(3,3,3-trifluoro-1-methyl-2-oxo-propylcarbamoyl)-methyl]-carbamoyl}-2-methyl-propyl)-benzamide 

Relevant articles and documents

Inhibition of human leukocyte elastase by N-substituted peptides containing α,α-difluorostatone residues at P1

A series of tripeptides which contain α,α-difluorostatone residues at P1-P1' and span the S3-S1' subsites have been shown to be potent inhibitors of human leukocyte elastase (HLE). The tripeptides described cont

Imidazo[1,2-a]piperazines

-